Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRETEC-EPO: Effect of erythropoietin on cognition and frontal lobe activity in remitted mood disorders
2016-004023-24Phase 2Completed
- Sponsor
- Copenhagen Affective Disorder Research Center
- Start
- Oct 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in bipolar disorder (BD) and major depressive disorder (MDD) comparing Eprex (erythropoietin) with Placebo (2 arms). Started Oct 2016; status: completed.
02
Drugs
epoetin alfa
03
Conditions
bipolar disorder (BD)major depressive disorder (MDD)
Beyond the preview
Go deeper on 2016-004023-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004023-24.